Stock Research for AXDX

AXDX
Current Price

$24.5000


Latest Update: 2018-02-20 16:00:00

High
$ 24.5500
Low
$ 24.5000
Close
$ 24.5500
Volume
10560
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

AXDX Stock Chart & Research Data

The AXDX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXDX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AXDX Due diligence Resources & Stock Charts

The AXDX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AXDX Detailed Price Forecast - CNN Money CNN View AXDX Detailed Summary - Google Finance
Yahoo View AXDX Detailed Summary - Yahoo! Finance Zacks View AXDX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AXDX Trends & Analysis - Trade-Ideas Barrons View AXDX Major Holders - Barrons
NASDAQ View AXDX Call Transcripts - NASDAQ Seeking View AXDX Breaking News & Analysis - Seeking Alpha
Spotlight View AXDX Annual Report - CompanySpotlight.com OTC Report View AXDX OTC Short Report - OTCShortReport.com
TradeKing View AXDX Fundamentals - TradeKing Charts View AXDX SEC Filings - Bar Chart
WSJ View Historical Prices for AXDX - The WSJ Morningstar View Performance/Total Return for AXDX - Morningstar
MarketWatch View the Analyst Estimates for AXDX - MarketWatch CNBC View the Earnings History for AXDX - CNBC
StockMarketWatch View the AXDX Earnings - StockMarketWatch MacroAxis View AXDX Buy or Sell Recommendations - MacroAxis
Bullish View the AXDX Bullish Patterns - American Bulls Short Pains View AXDX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AXDX Stock Mentions - StockTwits PennyStocks View AXDX Stock Mentions - PennyStockTweets
Twitter View AXDX Stock Mentions - Twitter Invest Hub View AXDX Investment Forum News - Investor Hub
Yahoo View AXDX Stock Mentions - Yahoo! Message Board Seeking Alpha View AXDX Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for AXDX - SECform4.com Insider Cow View Insider Transactions for AXDX - Insider Cow
CNBC View AXDX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AXDX - OTC Markets
Yahoo View Insider Transactions for AXDX - Yahoo! Finance NASDAQ View Institutional Holdings for AXDX - NASDAQ


Stock Charts

FinViz View AXDX Stock Insight & Charts - FinViz.com StockCharts View AXDX Investment Charts - StockCharts.com
BarChart View AXDX Stock Overview & Charts - BarChart Trading View View AXDX User Generated Charts - Trading View


Latest Financial News for AXDX

Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
Posted on Thursday February 15, 2018

TUCSON, Ariz., Feb. 15, 2018-- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company reported revenue for ...


See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.
Posted on Thursday February 15, 2018

Short interest is moderately high for AXDX with between 10 and 15% of shares outstanding currently on loan. Over the last one-month, outflows of investor capital in ETFs holding AXDX totaled $457 million.


Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
Posted on Thursday February 08, 2018

TUCSON, Ariz., Feb. 08, 2018-- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results for 2017.. President ...


What Are Accelerate Diagnostics’ Key Strengths?
Posted on Monday January 15, 2018

How Is Accelerate Diagnostics Positioned at the Start of 2018? In June 2017, Accelerate Diagnostics (AXDX) raised net proceeds of $83.2 million from a public offering of 2.8 million shares of common stock. As a result of the offering, the cash position of the company increased to $121.3 million at the end of 3Q17 as compared with $77.8 million at the end of 3Q16.


Accelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q4 2017 Results ...
Seeking Alpha - Feb 16, 2018
Forward-looking statements include statements pertaining to, among other things, the commercial launch and demand for the Accelerate Pheno system and Accelerate PhenoTest BC kit for positive blood cultures; the potential benefits of the Accelerate ...
Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017 - GlobeNewswire (press release)
Accelerate Diagnostics, Inc. (AXDX) Analysts See $-0.33 EPS - BZ Weekly

Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February ...
GlobeNewswire (press release) - Feb 8, 2018
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and healthcare-associated infections.
Accelerate Diagnostics, Inc. (AXDX) Reaches $23.65 After 4.00% Up Move ... - Norman Weekly
Reviewing BIOLASE (BIOL) and Accelerate Diagnostics (NASDAQ:AXDX) - Week Herald

Why Schuler Jack W Reported Accelerate Diagnostics, Inc Position?
Frisco Fastball - 10 hours ago
Moreover, Credit Suisse Ag has 0.04% invested in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) for 1.82M shares. Eaton Vance Management holds 0.01% or 223,215 shares.
Contrasting Cerner (CERN) and Accelerate Diagnostics (AXDX) - The Ledger Gazette

Accelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q3 2017 Results ...
Seeking Alpha - Nov 5, 2017
Forward-looking statements include statements pertaining to, among other things, the commercial launch and demand for the Accelerate Pheno system and Accelerate PhenoTest BC kit for positive blood cultures; the potential benefits of the Accelerate ...

Enter a stock symbol to view the stock details.